Corrigendum to “A review: Anti-obesity drug discovery from natural plant metabolites and endogenous peptides” [Curr. Res. Biotechnol. 8 (2024) 100259]

IF 3.6 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Current Research in Biotechnology Pub Date : 2025-01-01 DOI:10.1016/j.crbiot.2025.100289

Xiaomu Zhu , Dongdong Wang , Atanas G. Atanasov

引用次数: 0

查看原文本刊更多论文

“综述：从天然植物代谢物和内源性肽中发现的抗肥胖药物”的勘误表。生物技术学报，8 (2024)100259 [j]

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Research in Biotechnology Biochemistry, Genetics and Molecular Biology-Biotechnology

CiteScore

6.70

自引率

3.60%

发文量

审稿时长

38 days

期刊介绍： Current Research in Biotechnology (CRBIOT) is a new primary research, gold open access journal from Elsevier. CRBIOT publishes original papers, reviews, and short communications (including viewpoints and perspectives) resulting from research in biotechnology and biotech-associated disciplines. Current Research in Biotechnology is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is a companion to the highly regarded review journal Current Opinion in Biotechnology (2018 CiteScore 8.450) and is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.